itric oxide donors drugs for treatment of recurrent abortion due to primary antiphospholipid syndrome

Recruiting

• Conditions: recurrent abortion; primary antiphospholipid syndrome; Reproductive Health and Childbirth - Abortion; Inflammatory and Immune System - Autoimmune diseases

• Registration Number: ACTRN12613001085763
• Lead Sponsor: Benha university hospital

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2013-09-27
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: Recruiting
• Sex: Female
• Target Recruitment: 34

Inclusion Criteria

pregnant with recurrent abortion due to primary antiphospholipid syndrone

Exclusion Criteria

recurrent abortion due to anatomical, endocrine and other systemic diseases

Study & Design

• Study Type: Interventional
• Study Design: Not specified